PFS
CRDF icon

Prospera Financial Services’s Cardiff Oncology CRDF Stock Holding History

Prospera Financial Services’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,085
Closed -$10K – 1797
2022
Q1 		$10K Buy
+4,085
New +$14.4K ﹤0.01% 2020
2021
Q2 		– Sell
-26,650
Closed -$247K – 797
2021
Q1 		$247K Sell
26,650
-19,634
-42% -$239K 0.01% 671
2020
Q4 		$833K Buy
+46,284
New +$813K 0.06% 327
2020
Q3 		– Sell
-96,400
Closed -$483K – 1622
2020
Q2 		$483K Buy
96,400
+73,130
+314% +$150K 0.04% 359
2020
Q1 		$24K Sell
23,270
-8,100
-26% -$11.4K ﹤0.01% 505
2019
Q4 		$39K Buy
31,370
+21,253
+210% +$30.3K ﹤0.01% 591
2019
Q3 		$15K Buy
+10,117
New +$19.7K ﹤0.01% 542
2018
Q2 		– Sell
-1,769
Closed -$44K – 453
2018
Q1 		$44K Hold
1,769
– – 0.01% 434
2017
Q4 		$46K Buy
1,769
+14
+0.8% +$620 0.01% 391
2017
Q3 		$87K Sell
1,755
-81
-4% -$5.05K 0.01% 417
2017
Q2 		$156K Sell
1,836
-96
-5% -$6.18K 0.03% 404
2017
Q1 		$139K Sell
1,932
-111
-5% -$15.1K 0.03% 365
2016
Q4 		$338K Sell
2,043
-56
-3% -$13.1K 0.07% 249
2016
Q3 		$679K Sell
2,099
-90
-4% -$32.8K 0.14% 135
2016
Q2 		$714K Sell
2,189
-7
-0.3% -$2.41K 0.15% 124
2016
Q1 		$735K Buy
2,196
+80
+4% +$27.2K 0.16% 103
2015
Q4 		$823K Buy
2,116
+133
+7% +$52.1K 0.18% 85
2015
Q3 		$813K Buy
1,983
+570
+40% +$298K 0.21% 75
2015
Q2 		$1.03M Buy
+1,413
New +$1M 0.25% 74

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Prospera Financial Services's CRDF Position: Q2 2022 in Review

Prospera Financial Services sold out of Cardiff Oncology (CRDF) in Q2 2022, closing a stake of 4,085 shares — an estimated $10K sold.

Prospera Financial Services first reported a position in CRDF in Q2 2015 and held it in 19 quarters. The position peaked at $1.03M in Q2 2015. 67 funds tracked by Wall St. Rank hold CRDF as of Q2 2022.

  • Prospera Financial Services reported no remaining Cardiff Oncology position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 4,085 Cardiff Oncology shares in Q2 2022, an estimated $10K.
  • Prospera Financial Services first reported a position in Cardiff Oncology in Q2 2015 and held it in 19 quarters.
  • Prospera Financial Services's Cardiff Oncology position peaked at $1.03M in Q2 2015.
  • 67 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.